TOP STORIES

• BUSINESS 20 Companies Review Risk Countermeasures After Earthquake, Novartis Looks into MR Standards of Behavior: Jiho Survey
  March 9, 2012

• BUSINESS Daiichi Sankyo to Integrate Global, Japan Business Management Functions into Four-Division Structure
  March 8, 2012

• ORGANIZATION Wholesale Industry FTC to “Watch Closely” How Drug Makers Respond to Tougher Rules on Business Entertaining
  March 7, 2012

• BUSINESS Eisai to See 11%+, Lilly Japan 8-9% Average Price Reduction in FY2012 NHI Price Revision: Jiho Survey
  March 6, 2012

• REGULATORY 702 Products Including DPP-4 Inhibitors to Be Eligible for New Drug Premium in April
  March 5, 2012

• REGULATORY Private-Sector Members of Strategy Council Call for Early Establishment of Drug Discovery Support Organization
  March 5, 2012

• ORGANIZATION KSLION to Stimulate Innovation in Life Science in Japan: Prof. Y. Natsumeda
  March 5, 2012

• BUSINESS Medipal Group to Determine Profitability with Each Customer: Next President Shuichi Watanabe
  March 2, 2012

• BUSINESS DSP to Acquire Boston Biomedical, US Bioventure Specializing in Oncology
  March 1, 2012

• BUSINESS Pfizer Japan to Set Up Rare Disease Division
  February 29, 2012

• REGULATORY MHLW Conducts Hearing on Distribution Improvement with Drug Manufacturers
  February 28, 2012

• REGULATORY Next 5-Year Strategy Calls for Boost to Japanese“Rising Sun”Seed Development
  February 27, 2012

• REGULATORY PAFSC’s First Committee on Drugs Recommends Approval for Eli Lilly’s Once-Weekly GLP-1 Receptor Agonist
  February 27, 2012

• BUSINESS Diabetes Treatments: Their Development and Market (2)
  February 27, 2012

• BUSINESS Daiichi Sankyo and Terumo Codevelop Intradermal Vaccine
  February 24, 2012

• REGULATORY MEXT to Make Drug Education Compulsory at Junior High Schools from FY2012
  February 23, 2012

• BUSINESS Novo Nordisk President Says “Current Pipeline Most Substantial”
  February 22, 2012

• ORGANIZATION Japan Pharmaceutical Political Association Chairman Kumakura to Focus on Resolving Price Difference
  February 21, 2012

• REGULATORY MHLW Issues Improvement Order to Janssen Pharmaceutical for GMP Violation
  February 20, 2012

• BUSINESS Diabetes Treatments: Their Development and Market
  February 20, 2012

ページ

• « 先頭
• ‹ Prev
• …
• 237
• 238
• 239
• 240
• 241
• 242
• 243
• 244
• 245
• …
• Next ›
• 最終 »